R

Relay Therapeutics

324 employees

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Allosteric Drug Discovery
Protein Motion
Therapeutics
Chemistry
Computation
Biophysics
Health Care
Cancer Biology
Structural Biology
precision oncology

Date founded

2016

Funding rounds raised

Total raised

$400M

from 12 investors over 12 rounds

R

Relay Therapeutics raised $400M on December 20, 2018

Investors: D. E. Shaw Research, Foresite Capital, Perceptive Advisors, SoftBank Investment Advisers, Casdin Capital, LLC, GV and Tavistock Group

R

Relay Therapeutics raised $63M on December 14, 2017

Investors: GV, Casdin Capital, LLC, Third Rock Ventures and Section 32

R

Relay Therapeutics raised $57M on September 14, 2016

Investors: Third Rock Ventures

FAQ